{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:05:52Z","timestamp":1649120752349},"reference-count":21,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3960\/jslrt.55.23","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T22:05:48Z","timestamp":1435097148000},"page":"23-28","source":"Crossref","is-referenced-by-count":1,"title":["Lymphocyte-Rich Classical Hodgkin Lymphoma:"],"prefix":"10.3960","volume":"55","author":[{"given":"Jun","family":"Sakai","sequence":"first","affiliation":[{"name":"Department of Hematology, International Medical Center, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tanae","sequence":"additional","affiliation":[{"name":"Department of Hematology, Iwate Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, International Medical Center, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Pathology, International Medical Center, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Tamaru","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Center, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Niitsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, International Medical Center, Saitama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Stein H, Poppema S, Weiss LM, Anagnostopoulos I, Benharroch D, <i>et al<\/i>.: Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al<\/i>. (eds): WHO Classification of Tumors, Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.321-334, 2008"},{"key":"2","unstructured":"2 Br\u00e4uninger A, Wacker HH, Rajewsky K, K\u00fcppers R, Hansmann ML: Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin&apos;s lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin&apos;s lymphoma. Cancer Res. 63:1644-1651, 2003"},{"key":"3","unstructured":"3 Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, <i>et al<\/i>.: European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 96:1889-1899, 2000"},{"key":"4","unstructured":"5 Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, <i>et al<\/i>.: Lymphocyte-rich classical Hodgkin&apos;s lymphoma: distinctive tumor and microenvironment markers. Mod Pathol. 22:1006-1015, 2009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6 Garc\u00eda-Cos\u00edo M, Sant\u00f3n A, Mart\u00edn P, Camarasa N, Montalb\u00e1n C, <i>et al<\/i>.: Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin&apos;s lymphoma. Mod Pathol 17:1531-1538, 2004","DOI":"10.1038\/modpathol.3800227"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7 McCune RC, Syrbu SI, Vasef MA: Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin&apos;s and non-Hodgkin&apos;s lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol. 19:1010-1018, 2006","DOI":"10.1038\/modpathol.3800622"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Churchill HR, Roncador G, Warnke RA, Natkunam Y: Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol. 41:1726-1734, 2010","DOI":"10.1016\/j.humpath.2010.05.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9 Uherova P, Valdez R, Ross CW, Schnitzer B, Finn WG: Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience. Am J Clin Pathol. 119:192-198, 2003","DOI":"10.1309\/38RK238FCDCH5R22"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Kraus MD, Haley J: Lymphocyte predominance Hodgkin&apos;s disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis. Am J Surg Pathol. 24:1068-1078, 2000","DOI":"10.1097\/00000478-200008000-00004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, <i>et al<\/i>.: Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood. 99:1381-1387, 2002","DOI":"10.1182\/blood.V99.4.1381"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Chui DT, Hammond D, Baird M, Shield L, Jackson R, <i>et al<\/i>.: Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer. 38:126-136, 2003","DOI":"10.1002\/gcc.10266"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13 Hartmann S, Martin-Subero JI, Gesk S, H\u00fcsken J, Giefing M, <i>et al<\/i>.: Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin&apos;s lymphoma by array-based comparative genomic hybridization. Haematologica. 93:1318-1326, 2008","DOI":"10.3324\/haematol.12875"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Steidl C, Telenius A, Shah SP, Farinha P, Barclay L, <i>et al<\/i>.: Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood. 116:418-427, 2010","DOI":"10.1182\/blood-2009-12-257345"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, <i>et al<\/i>.: Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood. 97:1845-1853, 2001","DOI":"10.1182\/blood.V97.6.1845"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Advani RH, Hoppe RT: How I treat nodular lymphocyte predominant Hodgkin lymphoma. Blood. 122:4182-4188, 2013","DOI":"10.1182\/blood-2013-07-453241"},{"key":"16","unstructured":"17 Xing KH, Connors JM, Lai A, Al-Mansour M, Sehn LH, <i>et al<\/i>.: Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: A matched pair outcome analysis. Blood. 123:3567-3573, 2014"},{"key":"17","unstructured":"18 Fujii S, Miyata A, Ichimura K, Yoshino T: A case report considered intermediate type of nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. J Clin Exp Hematop. 103:47, 2007 (<i>Abstract in Japanese<\/i>)"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Brune V, Tiacci E, Pfeil I, D\u00f6ring C, Eckerle S, <i>et al<\/i>.: Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 205:2251-2268, 2008","DOI":"10.1084\/jem.20080809"},{"key":"19","unstructured":"20 Weiss LM, Hansmann ML, Chan JKC, M\u00fcller-Hermelink HK, Harris NL, <i>et al<\/i>.: Pathology of Hodgkin Lymphoma. In: Hoppe RT MM, Armitage JO, Diehl V, Weiss LM (eds): Hodgkin Lymphoma. 2nd ed, Philadelphia, Lippincott Williams &amp; Wilkins, 2007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Schmitz R, Stanelle J, Hansmann ML, K\u00fcppers R: Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 4:151-174, 2009","DOI":"10.1146\/annurev.pathol.4.110807.092209"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Schumacher MA, Schmitz R, Brune V, Tiacci E, D\u00f6ring C, <i>et al<\/i>.: Mutations in the genes coding for the NF-\u03baB regulating factors I\u03baB\u03b1 and A20 are uncommon in nodular lymphocyte-predominant Hodgkin&apos;s lymphoma. Haematologica. 95:153-157, 2010","DOI":"10.3324\/haematol.2009.010157"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:35:51Z","timestamp":1566923751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/55\/1\/55_23\/_article"}},"subtitle":["A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma"],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.55.23","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}